Tags

Type your tag names separated by a space and hit enter

Staphylococcus aureus bacteremia, Australia.
Emerg Infect Dis 2005; 11(4):554-61EI

Abstract

Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review was undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that approximately 6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB.

Authors+Show Affiliations

The Canberra Hospital, Garran, Australian Capital Territory, Australia. peter.collignon@act.gov.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15829193

Citation

Collignon, Peter, et al. "Staphylococcus Aureus Bacteremia, Australia." Emerging Infectious Diseases, vol. 11, no. 4, 2005, pp. 554-61.
Collignon P, Nimmo GR, Gottlieb T, et al. Staphylococcus aureus bacteremia, Australia. Emerging Infect Dis. 2005;11(4):554-61.
Collignon, P., Nimmo, G. R., Gottlieb, T., & Gosbell, I. B. (2005). Staphylococcus aureus bacteremia, Australia. Emerging Infectious Diseases, 11(4), pp. 554-61.
Collignon P, et al. Staphylococcus Aureus Bacteremia, Australia. Emerging Infect Dis. 2005;11(4):554-61. PubMed PMID: 15829193.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Staphylococcus aureus bacteremia, Australia. AU - Collignon,Peter, AU - Nimmo,Graeme R, AU - Gottlieb,Thomas, AU - Gosbell,Iain B, AU - ,, PY - 2005/4/15/pubmed PY - 2005/5/12/medline PY - 2005/4/15/entrez SP - 554 EP - 61 JF - Emerging infectious diseases JO - Emerging Infect. Dis. VL - 11 IS - 4 N2 - Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review was undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes, 1,571 (49%) were community onset. MRSA caused 40% of hospital-onset episodes and 12% of community-onset episodes. The median rate of SAB was 1.48/1,000 admissions (range 0.61-3.24; median rate for hospital-onset SAB was 0.7/1,000 and for community onset 0.8/1,000 admissions). Using these rates, we estimate that approximately 6,900 episodes of SAB occur annually in Australia (35/100,000 population). SAB is common, and a substantial proportion of cases may be preventable. The epidemiology is evolving, with >10% of community-onset SAB now caused by MRSA. This is an emerging infectious disease concern and is likely to impact on empiric antimicrobial drug prescribing in suspected cases of SAB. SN - 1080-6040 UR - https://www.unboundmedicine.com/medline/citation/15829193/Staphylococcus_aureus_bacteremia_Australia_ L2 - https://www.cdc.gov/ncidod/EID/vol11no04/04-0772.htm DB - PRIME DP - Unbound Medicine ER -